Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

France’s Loi Allègre (1999): The Legal Foundation for Researcher Entrepreneurship

France’s 1999 Loi Allègre first made it legal for public researchers to found, consult for, or hold equity in companies, and authorized public-research incubators — the legal foundation SATT and other French transfer infrastructure now operate within.

Before France built the regional SATT network that now handles most public-research technology transfer, it first had to make it legal for a public researcher to found a company at all. That legal foundation is the loi n°99-587 du 12 juillet 1999 sur l’innovation et la recherche — universally known, after the minister who championed it, as the Loi Allègre. This guide covers what the law actually did, why it was necessary, and how it relates to (and predates by more than a decade) the SATT companies that operate within the legal space it created.

Why a specific law was needed

French public researchers are, in most cases, civil servants (fonctionnaires) or public employees bound by statutory rules against holding outside commercial interests that conflict with their public duties. Before 1999, a CNRS researcher or university academic who wanted to found a startup around their own laboratory results faced a genuine legal obstacle, not just an institutional or cultural one: French public-service law generally prohibited a civil servant from owning a stake in, or directing, a private company engaged in an activity connected to their public duties. Turning a lab discovery into a company meant either resigning from the public research system entirely or working through informal, legally uncertain arrangements. Claude Allègre, then Minister of National Education, Research and Technology under the Jospin government, championed a law to remove that structural barrier and to give public research institutions an explicit mandate to support the process. The law was promulgated on 12 July 1999.

What the law actually created

The Loi Allègre did two distinct things, and both matter for understanding France’s later technology-transfer infrastructure.

1. Legal statuses letting researchers engage with private enterprise

The law inserted provisions — now codified in the French Research Code (Code de la recherche) rather than standing alone as originally drafted — creating several distinct authorized pathways for a public researcher to participate in a private company without simply resigning outright. In broad terms, these pathways cover: (1) taking leave from the public institution to found or join a company built on the researcher’s own work, generally subject to a time-limited authorization and a requirement that the public institution and the new company sign a formal valorization agreement; (2) providing paid scientific consulting (concours scientifique) to a company exploiting the researcher’s work while remaining a public employee, within defined time and compensation limits; and (3) holding an equity stake and/or a board seat in such a company while remaining employed by the public institution, again within defined ownership caps. Every pathway requires prior review and authorization by an ethics/deontology commission (the commission de déontologie, whose research-sector function has since been folded into the broader Haute Autorité pour la transparence de la vie publique framework) specifically to screen for conflicts of interest before authorization is granted. The exact percentage and compensation caps attached to each pathway have been adjusted by subsequent legislation — notably the 2019 loi PACTE, which relaxed several of the original 1999 limits — so an institution or researcher applying this today should confirm current figures against the Code de la recherche rather than the 1999 text itself; the structural principle (time-limited, ethics-reviewed, capped participation) has remained stable even as the specific numbers have moved.

2. A legal basis and funding call for public-research incubators

Articles 1 and 2 of the law authorized higher-education and research establishments — for the first time on an explicit statutory basis — to create or participate in incubation structures (structures d’incubation) dedicated to helping researchers and postgraduate students turn public-research results into high-technology companies, alongside complementary tools the law also enabled such as seed funds (fonds d’amorçage). In March 1999, ahead of and alongside the law’s passage, the ministry in charge of research launched a call for proposals that led to the creation of roughly thirty public-research incubators across France, generally attached to one or a group of universities, engineering schools, or research organizations in a given region. On the law’s 25th anniversary in 2024, industry reporting counted 19 of the original “Allègre incubators” still operating under that lineage, some having merged, rebranded, or been absorbed into later regional innovation infrastructure over the intervening quarter-century.

Founding law vs. operational network: why this is not the same topic as SATT

It is easy to conflate the Loi Allègre with the SATT network, since both sit in the same French public-research valorization story — but they are different things, created more than a decade apart, solving different problems:

  • The Loi Allègre (1999) is a legal-status law. It removed a statutory obstacle (civil-servant conflict-of-interest rules) and created the legal categories — leave-to-found, scientific consulting, capped equity/board participation — under which a French public researcher can lawfully engage with a private company at all. It also gave institutions explicit authority to fund and operate incubators. It does not itself run technology transfer operations, screen inventions, or negotiate licenses.
  • SATT (established 2010-2014) is operational infrastructure. The regional SATT companies are the professionally staffed entities that actually perform invention screening, patent prosecution, proof-of-concept funding, and licensing on behalf of member institutions — the day-to-day machinery of technology transfer. SATTs operate inside the legal space the Loi Allègre opened; a researcher whose SATT is negotiating a license, or who is being screened for spinout potential, is relying on legal statuses that trace back to the 1999 law even though the SATT itself did not exist until roughly a decade later.

In short: the Loi Allègre is the constitutional-style foundation — it made researcher entrepreneurship and public-research incubation legally possible and institutionally mandated. SATT is one particular operational model France later built on top of that foundation to run the transfer function at scale. A research-administration reader trying to understand why a French public researcher can hold equity in a spinout, or why a public institution can run an incubator at all, should look to the 1999 law; a reader trying to understand who actually processes an invention disclosure at a French university today should look to the SATT network (or, for institutions outside a SATT’s territory or scope, an in-house transfer office operating under the same 1999 legal statuses).

What the law means for research administrators today

  • It is still the operative legal basis. Any French public researcher’s involvement in a spinout — as founder, consultant, or equity holder — is authorized under provisions that descend directly from the Loi Allègre, now housed in the Code de la recherche and periodically amended (most significantly by the 2019 loi PACTE, which eased several of the original participation caps to encourage more researcher involvement).
  • Ethics review is a real, non-optional gate. Every pathway requires prior authorization from a deontology commission assessing conflict of interest — this is a compliance step, not a formality, and institutions supporting a faculty founder need to build it into their spinout-formation timeline.
  • Incubator affiliation predates and sits alongside SATT engagement. A French researcher’s project may pass through one of the surviving public-research incubators that trace their charter to the 1999 call for proposals, a regional SATT’s proof-of-concept process, or both, depending on the institution and region — they are not mutually exclusive, and international partners evaluating a French spinout deal may find both an incubator and a SATT in the cap table or governance history.

Frequently asked questions

What is the Loi Allègre in one sentence?

It is the French law of 12 July 1999 (loi n°99-587) that first gave public researchers a lawful, ethics-reviewed path to found, consult for, or hold equity in a private company built on their own research, and gave public research institutions explicit authority to create technology incubators.

Is the Loi Allègre the same thing as the SATT network?

No. The Loi Allègre is the 1999 legal-status framework; SATT is a network of regional technology-transfer companies created starting in 2010 that operates within that legal framework. See CASRAI’s guide to the SATT network for the operational model.

Are the original Loi Allègre incubators still around?

Some are. Industry reporting marking the law’s 25th anniversary in 2024 identified 19 incubators still operating under that original 1999-era lineage, out of roughly thirty created following the 1999 call for proposals — the rest have closed, merged, or been absorbed into other regional innovation structures over the past 25 years.

Has the law been amended since 1999?

Yes. Its researcher-participation provisions have been recodified into the Code de la recherche and adjusted by later legislation, most notably the 2019 loi PACTE, which relaxed several of the original ownership and participation limits. The core structural approach — time-limited, ethics-commission-reviewed authorization for founding, consulting, or equity participation — has remained in place.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →